Journal of the History of Biology

, Volume 49, Issue 2, pp 311–358 | Cite as

Bacterial Transformation and the Origins of Epidemics in the Interwar Period: The Epidemiological Significance of Fred Griffith’s “Transforming Experiment”

  • Pierre-Olivier Méthot


Frederick Griffith (1879–1941) was an English bacteriologist at the Pathological Laboratory of the Ministry of Health in London who believed that progress in the epidemiology and control of infectious diseases would come only with more precise knowledge of the identity of the causative microorganisms. Over the years, Griffith developed and expanded a serological technique for identifying pathogenic microorganisms, which allowed the tracing of the sources of infectious disease outbreaks: slide agglutination. Yet Griffith is not remembered for his contributions to the biology and epidemiology of infectious diseases so much as for discovering the phenomenon known as ‘transformation’. Griffith’s discovery, for many, was a pure case of serendipity whose biological relevance had also largely escaped him. In this paper, I argue that the key to understanding the significance of bacterial transformation – and the scientific legacy of Fred Griffith – rests not only on it initiating a cascade of events leading to molecular genetics but also on its implications for epidemiology based on the biology of host–parasite interactions. Looking at Griffith’s entire career, instead of focusing only on the transformation study, we can better appreciate the place of the latter within Griffith’s overall contributions. Presented in this way, Griffith’s experiment on bacterial transformation also ceases to appear as an anomaly, which in turn leads us to rethink some of the most prevalent historical conceptions about his work.


Epidemics Serological transformation Host–parasite interactions Virulence Bacteriology Evolution Oswald Avery Rebecca Lancefield Joshua Lederberg 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alloway, J.L. 1932. “The Transformation In Vitro of R Pneumococci into S Forms of Different Specific Types by the Use of Filtered Pneumococcus Extracts.” Journal of Experimental Medicine 55: 91–99.CrossRefGoogle Scholar
  2. Alloway, JL. 1933. “Further Observations on the Use of Pneumococcus Extracts in Effecting Transformation of Types In Vitro.” Journal of Experimental Medicine 57: 265–278.CrossRefGoogle Scholar
  3. Amsterdamska, O. 1987. “Medical and Biological Constraints: Early Research on Variation in Bacteriology.” Social Studies of Science 17: 657–687.CrossRefGoogle Scholar
  4. Amsterdamska, O. 1991. “Stabilizing Instability: The Controversy over Cyclogenic Theories of Bacterial Variation During the Interwar Period.” Journal of the History of Biology 24(2): 191–222.CrossRefGoogle Scholar
  5. Amsterdamska, O. 1993. “From Pneumonia to DNA: The Research Career of Oswald T. Avery.” Historical Studies in the Physical and Biological Sciences 24(1): 1–40.CrossRefGoogle Scholar
  6. Amsterdamska, O. 2004. “Achieving Disbelief: Thought Styles, Microbial Variation, and American and British Epidemiology, 1900–1940.” Studies in History and Philosophy of the Biological and Biomedical Sciences 35(3): 483–507.CrossRefGoogle Scholar
  7. Amsterdamska, O. 2005. “Demarcating Epidemiology.” Science, Technology, and Human Values 30(1): 17–51.CrossRefGoogle Scholar
  8. Andrews, F.W. 1914. “The Nature and Degree of Specific Differences Amongst Bacteria (Presidential Address).” Proceedings of the Royal Society of Medicine 7(Pathological Section): 1–15.CrossRefGoogle Scholar
  9. Arkwright, J.A. 1921. “Variation in Bacteria in Relation to Agglutination Both by Salts and by Specific Serum.” Journal of Pathology and Bacteriology 24: 36–60.CrossRefGoogle Scholar
  10. Arkwright, JA. 1929. “Virulence of the Micro-Organism in Infective Disease.” The Lancet 2: 963–968.Google Scholar
  11. Arkwright, JA. 1930. “Variation.” Medical Research Council (Great Britain), A System of Bacteriology in Relation to Medicine, 1 vols. London:His Majesty’s Stationary Office, pp. 311–374.Google Scholar
  12. Arkwright, J.A. 1931. “Variation of Bacteria.” R. Dujarric de la Rivière Gildmeister and Harry Plotz (eds), Microbiologie Générale Médicale, Vétérinaire et Agricole, Tome 1, Masson et Cie, pp. 141–161.Google Scholar
  13. Avery, O.T. 1915. “A Further Study on the Biologic Classification of Pneumococci.” Journal of Experimental Medicine 22(6): 804–819.CrossRefGoogle Scholar
  14. Avery, O.T. Chickering, H.T., Cole, R., and Dochez, A.R. 1917. Acute Lobar Pneumonia: Prevention and Serum Treatment. Monographs of the Rockefeller Institute for Medical Research, No. 7, New York.Google Scholar
  15. Avery, O.T, Dochez, A.R, Lancefield, R. 1919. “Studies on the Biology of Streptococcus. I. Antigenic Relationships Between Strains of Streptococcus haemolyticus.” The Journal of Experimental Medicine 30: 179.CrossRefGoogle Scholar
  16. Avery, O.T, MacLoed, Colin M, McCarty, Maclyn. 1944. “Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types.” The Journal of Experimental Medicine 79: 137–158.CrossRefGoogle Scholar
  17. Brock, T.D. 1990. The Emergence of Bacterial Genetics. Cold Spring Harbor:Cold Spring Harbor Laboratory Press.Google Scholar
  18. Brownlee, J. 1905. “Statistical Studies in Immunity. Natural Immunity and the Capacity for Acquiring Immunity in the Acute Infectious Diseases.” Journal of Hygiene 5(4): 514–535.CrossRefGoogle Scholar
  19. Burnet, F.M. 1968. Changing Patterns: An Atypical Autobiography. London:Heinemann.Google Scholar
  20. Chen, Ruey-Lin. 2010. “Experimental Discovery, Data Models, and Mechanisms in Biology: An Example from Mendel’s Work.” H-K Chao, et al. (eds.), Mechanisms and Causality in Biology and Economics. Dordrecht:Springer, pp. 101–122.Google Scholar
  21. Coburn, AF. 1969. “Oswald Theodore Avery and DNA.” Perspectives in Biology and Medicine 12(4): 623–630.CrossRefGoogle Scholar
  22. Cole, J.L, Wright, W.H. 1916. “Application of the Pure-Line Concept to Bacteria.” The Journal of Infectious Diseases 19(2): 209–221.CrossRefGoogle Scholar
  23. Conant, J.E, Sawyer, W.D. 1967. “Transformation During Mixed Pneumococcal Infection of Mice.” Journal of Bacteriology 93(6): 1869–1875.Google Scholar
  24. Creager, A.N.H. 2007. “Adaptation or Selection? Old Issues and New Stakes in the Postwar Debates over Bacterial Drug Resistance.” Studies in the History and Philosophy of the Biological and Biomedical Sciences 38: 159–190.CrossRefGoogle Scholar
  25. Cresto, E. 2008. “In Search of the Best Explanation About the Nature of the Gene: Avery on Pneumococcal Transformation.” Studies in the History of Biological and Biomedical Sciences 39: 65–79.CrossRefGoogle Scholar
  26. Cushing, H.B. 1922. “Experimental Epidemiology (Editorial).” The Canadian Medical Association Journal 18(4): 430–431.Google Scholar
  27. Dawson, M.H. 1928. “The Interconvertibility of ‘R’ and ‘S’ Forms of Pneumococcus.” Journal of Experimental Medicine 47(4): 577–591.CrossRefGoogle Scholar
  28. Dawson, MH. 1930. “The Transformation of Pneumococcal Types: I. The Conversion of R Forms of Pneumococcus into S Forms of the Homologous type [and] II. The Interconvertibility of Type-Specific S. pneumococci.” Journal of Experimental Medicine 51(1): 99–147.CrossRefGoogle Scholar
  29. Dawson, M.H. and Sia, R.H.P. 1931. “In vitro transformation of pneumococcal types.” Journal of Experimental Medicine 54(5): 701–710.CrossRefGoogle Scholar
  30. Deichmann, U. 2004. “Early Responses to Avery et al’.s Paper on DNA as Hereditary Material.” Historical Studies in the Physical and Biological Sciences 34(2): 207–232.Google Scholar
  31. Dobzhansky, T. 1941. Genetics and the Origins of Species, 2nd ed. New York: Columbia University Press.Google Scholar
  32. Dochez, A.R, Avery, Oswald. 1915. “Varieties of Pneumococcus and Their Relation to Lobar Pneumonia.” Journal of Experimental Medicine 21(2): 114–132.CrossRefGoogle Scholar
  33. Downie, A.W. 1972. “Pneumococcal Transformation – A Backward View. Fourth Griffith Memorial Lecture.” Journal of General Microbiology 73: 1–11.CrossRefGoogle Scholar
  34. Dubos, R.J. 1956. “Owsald Theodore Avery. 1877–1955.” Biographical Memoir of Fellows of the Royal Society 2: 35–48.CrossRefGoogle Scholar
  35. Dubos, RJ. 1976. The Professor, the Institute, and DNA. New York:The Rockefeller University Press.Google Scholar
  36. Eastwood, A. 1923. “Bacterial Variation and Transmissible Autolysis.” Reports of the Local Government Board on Public Health and Medical Subjects No. 18. Ministry of Health. London: His Majesty Stationary Office, pp. 14–34.Google Scholar
  37. Eichmann, K, Krause, Richard. 2013. “Fred Neufeld and Pneumococcal Serotypes: Foundations for the Discovery of the Transforming Principle.” Cellular and Molecular Life Sciences 70: 2225–2236.CrossRefGoogle Scholar
  38. English, P.C. 1989. “Emergence of Rheumatic Fever in the Nineteenth Century.” The Milbank Quarterly 67: 33–49.CrossRefGoogle Scholar
  39. English, PC. 2002. Rheumatic Fever in Britain and America: A Biological, Epidemiological, and Medical History. New Brunswick, NJ:Rutgers University Press.Google Scholar
  40. Final Report of the Royal Commission on Tuberculosis. 1911. British Medical Journal, July 15th, 122–125Google Scholar
  41. Fleck, L. 1935/1979. Genesis and Development of a Scientific Fact. Chicago: Chicago University Press.Google Scholar
  42. Francis, J. 1959. “The Work of the British Commission on Tuberculosis, 1901–1911.” Tubercle 40(2): 124–132.Google Scholar
  43. Gayon, J. 1995. “Les premiers pastoriens et l’hérédité.” Bulletin de la société d’histoire et d’épistémologie des sciences de la vie 2: 193–204.Google Scholar
  44. Gilbert, R. 1928. “The Complement Fixation Test for Syphilis.” Edwin O. Jordan and J.S. Falk (eds), The Newer Knowledge of Bacteriology and Immunology. Chicago: The University of Chicago Press, pp. 838–847.Google Scholar
  45. Glover, J.A. 1930a. “Milroy Lectures on the Incidence of Rheumatic Diseases.” The Lancet 1: 499–505.Google Scholar
  46. Glover, J.A Fred Griffith. 1930a. “Acute Tonsillitis and Some of Its Sequels: Epidemiological and Bacteriological Observations.” The British Medical Journal 2(3689): 521–527.CrossRefGoogle Scholar
  47. Glover, J.A, Griffith, Fred. 1930b. “An Outbreak of Scarlet Fever at a Preparatory School.” The Lancet 216: 815–817.CrossRefGoogle Scholar
  48. Gradmann, C. 2000. “Isolation, Contamination, and Pure Culture: Monomorphism and Pleomorphism of Pathogenic Micro-Organisms as Research Problems 1860–1880.” Perspectives on Science 9(2): 147–172.CrossRefGoogle Scholar
  49. Gradmann, C. 2014. “A Spirit of scientific Rigour: Koch’s Postulates in Twentieth-Century Medicine.” Microbes and Infection 16: 885–892.CrossRefGoogle Scholar
  50. Gradmann, C, Simon, Jonathan (eds.). 2010. Evaluating and Standardizing Therapeutic Agents, 1890–1950. Basingstoke:Palgrave MacMillan.Google Scholar
  51. Greenwood, M, Topley, WilliamW.C. 1926. “Experimental Epidemiology: Some General Considerations.” Proceedings of the Royal Society of Medicine 19: 31–44.Google Scholar
  52. Griffith, S. A. 1901. “The Flora of the Conjunctiva in Health and Disease.” Rubert Boyce and C.S. Sherrington (eds), Thompson Yates Laboratories Report, Vol. 4, Part 1. Liverpool University Press, Liverpool, pp. 99–148.Google Scholar
  53. Griffith, S.A. 1907. “Report on the Changes in Reaction Produced in Broth by Human and Bovine Tubercle Bacilli.” Second Interim Report of the Royal Commission Appointed to Inquire into the Relations of Human and Animal Tuberculosis. London: Her Majesty’s Stationary Office.Google Scholar
  54. Griffith, S.A. and Griffith, F. 1907. Royal Commission on Tuberculosis. The Pathogenic Effects of Bovine Viruses. The British Medical Journal 2(2430): 210–213.Google Scholar
  55. Griffith, S.A. 1937. “Types of Tubercle Bacilli in Equine Tuberculosis.” Journal of Comparative Pathology and Therapeutics 50: 159–172.CrossRefGoogle Scholar
  56. Griffith, F. 1911. “Modification experiments with tubercle bacilli derived from animals other than man”, In A. S. Griffith & F. Griffith (eds.), Final Report of the Royal Commission on Tuberculosis, Part II, Appendix, Vol. III. London: His Majesty's Stationary Office, pp. 383–391Google Scholar
  57. Griffith, F. 1917. “Second Report on the Identification of the Meningococcus in the Naso-pharynx, with Special Reference to Serological Reactions.” Journal of Hygiene 17(2/3): 124–190.Google Scholar
  58. Griffith, F. 1921. “Cerebro-spinal Fever and Meningococcus Types.” The British Medical Journal 2(3183): 1130.CrossRefGoogle Scholar
  59. Griffith, F. 1922. “Types of Pneumococci.” In Reports to the Local Government Board on Public Health and Medical Subjects No. 13. Ministry of Health. London: His Majesty Stationary Office, pp. 20–45.Google Scholar
  60. Griffith, F. 1923. “The Influence of Immune Serum on the Biological Properties of Pneumococci.” Reports of the Local Government Board on Public Health and Medical Subjects No. 18. Ministry of Health. London: His Majesty Stationary Office, pp. 1–13.Google Scholar
  61. Griffith, F. 1927. “Types of Haemolytic Streptococci in Relation to Scarlet Fever (Second Report).” Journal of Hygiene 26(4): 363–373.CrossRefGoogle Scholar
  62. Griffith, F. 1928. “The Significance of Pneumococcal Types.” Journal of Hygiene 27(2): 113–159.CrossRefGoogle Scholar
  63. Griffith, F. 1929. “Serological Races of Pneumococci.” A System of Bacteriology in Relation to Medicine, Medical Research Council. Edinburgh: Her Majesty’s Stationary Office, London, pp. 201–225.Google Scholar
  64. Griffith, F. 1934. “The Serological Classification of Streptococcus pyogenes.” Journal of Hygiene 34(4): 542–584.CrossRefGoogle Scholar
  65. Griffith, F. 1937. “The Agglutination of Haemolytic Streptococci.” R. St-John-Brooks (ed.), Report of Proceedings. Second International Congress for Microbiology, London, 25 July–1 August, 1935, pp. 132–133.Google Scholar
  66. Griffith, F. and Scott, William MacDonald. 1920. “Technique of the Wassermann Reaction.” Report on Public Health and Medical Subjects, No. I(7). London: Ministry of Health.Google Scholar
  67. Gunn, W, Griffith, Fred. 1926. “Bacteriological and Clinical Study of One Hundred Cases of Scarlet Fever.” Journal of Hygiene 28(3): 250–266.CrossRefGoogle Scholar
  68. Hadley, P. 1927. “Microbic Dissociation: The Instability of Bacterial Species with Special Reference to Active Dissociation and Transmissible Autolysis.” The Journal of Infectious Diseases 40(10): 1–312.CrossRefGoogle Scholar
  69. Hamer, W.H. 1906. “The Milroy Lectures on Epidemic Disease in England – The Evidence of Variability and of Persistency of Type.” The Lancet 167: 569–574.CrossRefGoogle Scholar
  70. Hare, R. 1940. “Sources of Hemolytic Streptococcal Infections of Wounds in War and in Civil Life.” The Lancet 238: 109–111.CrossRefGoogle Scholar
  71. Hayes, W. 1966. “Genetic Transformation: A Retrospective appreciation. First Griffith Memorial Lecture.” Journal of General Microbiology 45: 385–397.CrossRefGoogle Scholar
  72. Hotchkiss, R.D. 1966. Gene, transforming principle, and DNA. J. Cairns, G.S. Stent, & J.D. Watson (eds.), Phages and the origins of molecular biology. Cold Spring Harbor:Cold Spring Harbor Laboratory Press, pp. 180–200.Google Scholar
  73. Hüntelmann, AC. 2010. “Evaluation as a Practical Technique of Administration: The Regulation and Standardization of Diphtheria Serum.” Christoph Gradmann, Jonathan Simon (eds.), Evaluating and Standardizing Therapeutic Agents, 1890–1950. Basingstoke:Palgrave MacMillan, pp. 31–51.Google Scholar
  74. Jacob, F. 1973. The Logic of Life. A History of Heredity (Trans. Betty E. Spillmann). New York: Pantheon Books.Google Scholar
  75. Judson, H.F. 1996. The Eight Day of Creation: the Makers of the Revolution in Biology. Cold Spring Harbor:Cold Spring Harbor Laboratory Press.Google Scholar
  76. Kay, L.E. 2000. Who wrote the Book of Life? A History of the Genetic Code. California:Stanford University Press.Google Scholar
  77. Kohler, R.E. 2002. Landscapes and Labscapes. Exploring the Lab-Field Border. Chicago:Chicago University Press.CrossRefGoogle Scholar
  78. Lagnado, J. 2005. “From Pabulum to Prions (via DNA): A Tale of Two Griffiths.” The Biochemist 27(4): 33–35.Google Scholar
  79. Lancefield, R. 1933. “A Serological Differentiation of Human and Other Groups of Hemolytic Streptococci.” Journal of Experimental Medicine 57(4): 571–595.CrossRefGoogle Scholar
  80. Lederberg, J. 1992. “Bacterial Variation Since Pasteur. Rummaging in the Attic: Antiquarian Ideas of Transmissible Heredity, 1880–1940.” ASM News 58(5): 262–265.Google Scholar
  81. Loison, L. 2011. “French Roots of Neo-Lamarckisms, 1879–1985.” Journal of the History of Biology 44: 713–744.CrossRefGoogle Scholar
  82. Löwy, I. 1988. “The Scientific Roots of Constructivist Epistemologies: Hélène Metzger and Ludwik Fleck.” G. Freudenthal (ed), Studies on Hélène Metzger, 8/9. Paris: Corpus, pp. 219–235.Google Scholar
  83. Luria, S. 1947. “Recent Advances in Bacterial Genetics.” Bacteriological Reviews 11: 1–40.Google Scholar
  84. Mazumdar, P.M.H. 1995. Species and Specificity. An Interpretation of the History of Immunology. Cambridge:Cambridge University Press.Google Scholar
  85. Mazumdar, PMH. 2010. “The State, the Serum Institutes and the League of Nations.” Christoph Gradmann, Jonathan Simon (eds.), Evaluating and Standardizing Therapeutic Agents, 1890–1950. Basingstoke:Palgrave MacMillan, pp. 118–138.Google Scholar
  86. McCarty, M. 1985. The Transforming Principle. The Discovery that Genes are made of DNA. New York:W.W. Norton.Google Scholar
  87. McCarty, M. 1987. Rebecca Craighill Lancefield 1895–1981. A Biographical Memoir. Washington, D.C.: National Academy of Sciences.Google Scholar
  88. Medawar, P. 1968. “Lucky Jim.” The New York Review of Books 10(6): 3–5.Google Scholar
  89. Mendelsohn, J.A. 1998. “From Eradication to Equilibrium: How Epidemics Became Complex After World War I.” Christopher Lawrence, George Weisz (eds.), Greater than the Parts: Holism in Biomedicine. Oxford:Oxford University Press, pp. 303–331.Google Scholar
  90. Mendelsohn, JA. 2002. ““Like All that Lives”: Biology and Medicine in the Age of Pasteur and Koch.” History and Philosophy of the Life Sciences 24: 3–36.CrossRefGoogle Scholar
  91. Méthot, P.-O. 2012. “Why Do Parasites Harm Their Host? On the Origin and Legacy of Theobald Smith’s ‘Law of Declining Virulence’ – 1900–1980.” History and Philosophy of the Life Sciences 34: 561–601.Google Scholar
  92. Méthot, P.-O. and Alizon, S. 2014. “Emerging Disease and the Evolution of Virulence – The Case of the 1918–19 Influenza Pandemic.” P. Huneman, G. Lambert, and M. Silberstein (eds), Classification, Disease and Evidence: New Essays in the Philosophy of Medicine, Chap. 5. Dordrecht: Springer, pp. 93–130.Google Scholar
  93. Morange, M. 1998. A History of Molecular Biology. Harvard University Press, Cambridge [1993].Google Scholar
  94. Morgan, W.T.J. 1944. “Transformation of Pneumococcal Types.” Nature 3895: 763–764.CrossRefGoogle Scholar
  95. Morgenroth, J., Schnitzer, R., and Berger E. 1925. […] Zeitschrift für immunitätforschung 96(167): 1–292.Google Scholar
  96. Moulin, A.M. 1992. “La Métaphore Vaccine.” History and Philosophy of the Life Sciences 14(2): 271–297.Google Scholar
  97. Neufeld, F, Händel, L. 1909. “Uber die herstellung von pneumokokkenserum und über die aussichten einer spezifischen behandlung der pneumonie.” Zeitschrift für immunitätforschung 3: 159–171.Google Scholar
  98. Neufeld, F, Händel, L. 1912. “Zur frage der serumtherapie der pneumonie und der wertbestimmun des pneumokokken-serums.” Berliner Klinische Wochenschrift 49: 680–683.Google Scholar
  99. Neufeld, F, Levinthal, W. 1928. “Beiträge zur variabilität der pneumokokken.” Zeitschrift für immunitätforschung 55: 324–340.Google Scholar
  100. O’Hern, E.M. 1975. “Rebecca Craighill Lancefiled, Pioneer Microbiologist.” ASM News 41(12): 805–810.Google Scholar
  101. Olby, R. 1994. The Path to the Double Helix. The Discovery of DNA. Foreword by Francis Crick. New York: Dover Publications [1974].Google Scholar
  102. O’Malley, M.A. 2009. “What did Darwin Say About Microbes, and How Did Microbiology Respond?” Trends in Microbiology 17(8): 341–347.Google Scholar
  103. Parker, M.T. 2001. “Winston R. Maxted and the Type Specificity of Group A Streptococci.” Journal of Medical Microbiology 50: 1–3.Google Scholar
  104. Podolsky, S.H. 2006. Pneumonia Before Antibiotics. Baltimore:Johns Hopkins University Press.Google Scholar
  105. Pollock, M.R. 1970. “The Discovery of DNA: An Ironic Tale of Chance, Prejudice, and Insight. Third Griffith Memorial Lecture.” Journal of General Microbiology 63: 1–20.CrossRefGoogle Scholar
  106. Reimann, H.A. 1929. “The reversion of R. to S. pneumococci.” Journal of Experimental Medicine. 49(2): 237–249.Google Scholar
  107. Ritchie, C. 1907. “Foreword to Edward the Seventh.” Second Interim Report of the Royal Commission Appointed to Inquire into the Relations of Human and Animal Tuberculosis. London: Her Majesty’s Stationary Office, Part I, pp. 3–4.Google Scholar
  108. Rosenkrantz, B.G. 1985. “The Trouble with Bovine Tuberculosis.” Bulletin of the History of Medicine 59: 155–175.Google Scholar
  109. Russel, N. 1988. “Oswald Avery and the Origin of Molecular Biology.” The British Journal for the History of Science 21(4): 393–400.CrossRefGoogle Scholar
  110. Sapp, J. 1994. Evolution by Association. A History of Symbiosis. New York:Oxford University Press.Google Scholar
  111. Steere-Williams, J. 2015. 1870–1900. “Performing state medicine during its 'frustrating' years: Epidemiology and bacteriology at the Local Government Board.” Social History of Medicine 28(1): 82–107Google Scholar
  112. Stegenga, J. 2011. “The Chemical Characterization of the Gene. Vicissitudes of Evidential Assessment.” History and Philosophy of the Life Sciences 33: 105–127.Google Scholar
  113. Swedlund, A.C. and Donta, Alison K. 2003. “Scarlet Fever Epidemics of the Nineteenth Century: A Case of Evolved Pathogenic Virulence?” D. Ann Herring and Alan C. Swedlund (eds), Human Biologists in the Archives: Demography, Health, Nutrition and Genetics. Cambridge: Cambridge University Press.Google Scholar
  114. The Thompson Yates and Johnston Laboratory Report, 1903. London: The University Press of LiverpoolGoogle Scholar
  115. Topley, W.W.C. 1941. The Biology of Epidemics. The Croonian Lecture. Proceedings of the Royal Society of London B, Biological Sciences 130(861): 337–359.Google Scholar
  116. Topley, W.W.C, Graham, SWilson. 1934. The Principles of Bacteriology and Immunity, 2nd ed. Baltimore:William Wood & Company.Google Scholar
  117. Travassos, L.R. 1979. “Bacterial Transformation Revisited: Familiar and Unfamiliar Results of the 1920–1930 Decade.” ASM News 45: 420–422.Google Scholar
  118. Wright, H.D. 1941. Obituary. William McDonald Scott and Frederick Griffith. The Lancet 588–589.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  1. 1.Faculté de philosophieUniversité LavalQuébecCanada
  2. 2.Centre interuniversitaire de recherche sur la science et la technologieUniversité du Québec à MontréalMontréalCanada

Personalised recommendations